Umbilical Cord Derived Mesenchymal Stem Cell（Wuhan Union Hospital）

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameUmbilical Cord Derived Mesenchymal Stem Cell（Wuhan Union Hospital）
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHemorrhageNeutropeniaThrombocytopenia +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWuhan Union HospitalThe Center Hospital Of WuhanTongji Hospital Tongji Of Huazhong University Of Science & Technology, China
China Registration ClassN/A

Develop Information

Active CompaniesThe Center Hospital Of WuhanWuhan Union HospitalTongji Hospital Tongji Of Huazhong University Of Science & Technology, China
Inactive CompaniesN/A
Active IndicationsHemorrhageNeutropeniaThrombocytopenia +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A